Does catheter ablation improve symptoms and patient satisfaction in patients with supraventricular tachycardia?
Catheter ablation for SVT yields high patient satisfaction at 1 year, but AFL patients require careful follow-up and anticoagulation due to high stroke and mortality rates.
Ablation therapy for SVT is a safe procedure bringing symptomatic improvement and satisfaction to three quarters of patients after 1 year. Even in patients with arrhythmia recurrence, a high satisfaction level and adherence to the ablating institution could be documented. Strikingly high mortality and stroke rates in follow-up were observed in AFL patients, who apparently need consistent long-term anticoagulation and more medical attention.
Brachmann et al. (Thu,) studied this question.